BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22050420)

  • 1. The erythropoietin-derived peptide mimetic pHBSP affects cellular and cognitive consequences in a rat post-status epilepticus model.
    Seeger N; Zellinger C; Rode A; Roloff F; Bicker G; Russmann V; Fischborn S; Wendt H; Potschka H
    Epilepsia; 2011 Dec; 52(12):2333-43. PubMed ID: 22050420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting epileptogenesis-associated induction of neurogenesis by enzymatic depolysialylation of NCAM counteracts spatial learning dysfunction but fails to impact epilepsy development.
    Pekcec A; Fuest C; Mühlenhoff M; Gerardy-Schahn R; Potschka H
    J Neurochem; 2008 Apr; 105(2):389-400. PubMed ID: 18194217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the erythropoietin-derived peptide mimetic Epotris on the histopathological consequences of status epilepticus.
    Zellinger C; Seeger N; Hadamitzky M; Fischborn S; Russmann V; Wendt H; Pankratova S; Bock E; Berezin V; Potschka H
    Epilepsy Res; 2011 Oct; 96(3):241-9. PubMed ID: 21741213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.
    Brandt C; Glien M; Gastens AM; Fedrowitz M; Bethmann K; Volk HA; Potschka H; Löscher W
    Neuropharmacology; 2007 Aug; 53(2):207-21. PubMed ID: 17585956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model.
    Licko T; Seeger N; Zellinger C; Russmann V; Matagne A; Potschka H
    Epilepsia; 2013 Jul; 54(7):1176-85. PubMed ID: 23614482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation.
    van Vliet EA; Forte G; Holtman L; den Burger JC; Sinjewel A; de Vries HE; Aronica E; Gorter JA
    Epilepsia; 2012 Jul; 53(7):1254-63. PubMed ID: 22612226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
    Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
    Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin pre-treatment prevents cognitive impairments following status epilepticus in rats.
    Jun Y; JiangTao X; YuanGui H; YongBin S; Jun Z; XiaoJun M; JianChun X; Heng X; XiaoXin Z; XinXiang X
    Brain Res; 2009 Jul; 1282():57-66. PubMed ID: 19497315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CNTF-derived peptide mimetic Cintrofin attenuates spatial-learning deficits in a rat post-status epilepticus model.
    Russmann V; Seeger N; Zellinger C; Hadamitzky M; Pankratova S; Wendt H; Bock E; Berezin V; Potschka H
    Neurosci Lett; 2013 Nov; 556():170-5. PubMed ID: 24120433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin reduces epileptogenic processes following status epilepticus.
    Chu K; Jung KH; Lee ST; Kim JH; Kang KM; Kim HK; Lim JS; Park HK; Kim M; Lee SK; Roh JK
    Epilepsia; 2008 Oct; 49(10):1723-32. PubMed ID: 18479396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term neuronal replacement in adult rat hippocampus after status epilepticus despite chronic inflammation.
    Bonde S; Ekdahl CT; Lindvall O
    Eur J Neurosci; 2006 Feb; 23(4):965-74. PubMed ID: 16519661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the NCAM derived mimetic peptide plannexin on the acute cellular consequences of a status epilepticus.
    Zellinger C; Hadamitzky M; Bock E; Berezin V; Potschka H
    Neurosci Lett; 2011 Sep; 501(3):173-8. PubMed ID: 21787839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline fails to exert antiepileptogenic effects in a rat status epilepticus model.
    Russmann V; Goc J; Boes K; Ongerth T; Salvamoser JD; Siegl C; Potschka H
    Eur J Pharmacol; 2016 Jan; 771():29-39. PubMed ID: 26681545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus.
    Cunha AO; Mortari MR; Liberato JL; dos Santos WF
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):470-7. PubMed ID: 19371260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic treatment with melatonin after status epilepticus: effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy.
    Tchekalarova J; Petkova Z; Pechlivanova D; Moyanova S; Kortenska L; Mitreva R; Lozanov V; Atanasova D; Lazarov N; Stoynev A
    Epilepsy Behav; 2013 Apr; 27(1):174-87. PubMed ID: 23435277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of food deprivation during early development on cognition and neurogenesis in the rat.
    Akman C; Zhao Q; Liu X; Holmes GL
    Epilepsy Behav; 2004 Aug; 5(4):446-54. PubMed ID: 15256180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow mononuclear cells reduce seizure frequency and improve cognitive outcome in chronic epileptic rats.
    Venturin GT; Greggio S; Marinowic DR; Zanirati G; Cammarota M; Machado DC; DaCosta JC
    Life Sci; 2011 Aug; 89(7-8):229-34. PubMed ID: 21718708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of levetiracetam on visual-spatial memory following status epilepticus.
    Zhou JL; Zhao Q; Holmes GL
    Epilepsy Res; 2007 Jan; 73(1):65-74. PubMed ID: 17029741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvacrol after status epilepticus (SE) prevents recurrent SE, early seizures, cell death, and cognitive decline.
    Khalil A; Kovac S; Morris G; Walker MC
    Epilepsia; 2017 Feb; 58(2):263-273. PubMed ID: 28084627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of pharmacoresistant epilepsy: pharmacoresistant rats differ from pharmacoresponsive rats in behavioral and cognitive abnormalities associated with experimentally induced epilepsy.
    Gastens AM; Brandt C; Bankstahl JP; Löscher W
    Epilepsia; 2008 Oct; 49(10):1759-76. PubMed ID: 18494789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.